tiprankstipranks
Trending News
More News >
Virpax Pharmaceuticals (VRPX)
OTHER OTC:VRPX
US Market

Virpax Pharmaceuticals (VRPX) Income Statement

Compare
216 Followers

Virpax Pharmaceuticals Income Statement

Last quarter (Q4 2024), Virpax Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Virpax Pharmaceuticals's net income was $-3.39M. See Virpax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.08B$ 15.69M$ 21.85M$ 12.03M$ 4.20M
Depreciation and Amortization
$ 91.04M$ 500.28K$ 18.35M$ 12.03M$ 4.20M
EBITDA
$ -12.08B$ -14.69M$ 0.00$ 0.00$ 4.00K
Operating Income
$ -12.08B$ -15.69M$ -21.85M$ -12.03M$ -4.20M
Other Income/Expenses
$ 12.71M$ 500.28K$ 194.41K$ -30.56K$ -143.93K
Pretax Income
$ -12.07B$ -15.19M$ -21.65M$ -12.06M$ -4.34M
Net Income
$ -12.07B$ -15.19M$ -21.46M$ -12.15M$ -4.49M
Per Share Metrics
Basic EPS
$ -2.84K$ -12.97$ -18.32$ -10.37$ -9.07
Diluted EPS
$ -2.84K$ -12.97$ -18.32$ -10.37$ -9.07
Weighted Average Shares Outstanding
4.25M 1.17M 1.17M 1.17M 494.51K
Weighted Average Shares Outstanding (Diluted)
4.25M 1.17M 1.17M 1.17M 494.51K
Currency in USD

Virpax Pharmaceuticals Earnings and Revenue History